TERM ID="NYU_TERM_1" STRING="abatacept treatment" FREQUENCY=1 START=302 END=321 LEMMA="ABATACEPT TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="hepatitis B" FREQUENCY=2 START=126 END=137 LEMMA="HEPATITIS B" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_3" STRING="hepatitis B" FREQUENCY=2 START=230 END=241 LEMMA="HEPATITIS B" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_4" STRING="hepatitis B virus" FREQUENCY=1 START=36 END=53 LEMMA="HEPATITIS B VIRUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="infection" FREQUENCY=1 START=253 END=262 LEMMA="INFECTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="rheumatic diseases" FREQUENCY=2 START=13 END=31 LEMMA="RHEUMATIC DISEASE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_7" STRING="rheumatic diseases" FREQUENCY=2 START=385 END=403 LEMMA="RHEUMATIC DISEASE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_8" STRING="rheumatological patients" FREQUENCY=1 START=85 END=109 LEMMA="RHEUMATOLOGICAL PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="rituximab" FREQUENCY=1 START=278 END=287 LEMMA="RITUXIMAB" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="therapeutic recommendations" FREQUENCY=1 START=326 END=353 LEMMA="THERAPEUTIC RECOMMENDATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="tocilizumab" FREQUENCY=1 START=289 END=300 LEMMA="TOCILIZUMAB" LEMMA_FREQUENCY=1
